chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the flu and COVID-19 vaccine on the same day. I do not know which one is to blame for my delayed and strong reaction. I want to report my symptoms since receiving the vaccines because 1) the timing of symptoms is not as expected (delayed by several days) and 2) symptoms are bad. I received the vaccine on Friday around lunchtime. I did not feel that bad over the weekend at all, just a terrible runny nose. I didn't even have much pain in my arm. But by Tuesday morning, I was feeling sick. My throat hurt and I was coughing a lot, sometimes productively with a bit of phlegm. And my nose is running constantly and eyes are tearing. I have a mild headache. Very fatigued. It is Thursday and I still feel miserable. No one else in my household is sick. My husband and I have 3 children. My husband got the vaccines the Tuesday before I did and he had a similar reaction - very congested and runny nose for several days. His symptoms, while the same as mine, did not seem to be as delayed as mine but lasted longer than the guidance states.   The information regarding the vaccines should be updated to state that symptoms can persist 3 - 7 days after getting the vaccine, rather than will be resolved by day 3, if others are reporting this as well.   While I am generally a proponent of vaccines, and have recovered well from flu vaccines in the past, my reaction this time will certainly make me think twice before getting a COVID-19 vaccine again. And/or may choose not to get both on the same day.
Patient began feeling dizzy at 0915. Patient denies Headache, Chest pain, SOB difficulty swallowing or pruritis. Patient denies any Past Medical History. Denies taking any medications and denies having allergies to medications. Patient describes only experiencing seasonal allergies. Patient Vitals Temp 98.3, HR 60, BP 120/80, Spo2 98% on Room air. Cardiovascular: RRR, Lungs: CTA B/L. Neuro:dizziness. Patient was given oral hydration.  0930- Patient complained of dyspnea and scratchy throat. Patient still denies Chest pain, difficulty swallowing, headache. Patient reports dizziness has resolved. Patient appears in no acute distress. Pulseox 98% room air . HR 62. No oral pharyngeal edema noted. Patient was treated as a possible allergic reaction Benadryl 25mg and Pepcid 20mg administered. Patient was monitored for an additional 20 minutes. Patient reports dyspnea and dizziness resolved, in addition to itchiness in the throat.   Patient was discharged home instructed to call PCP if symptoms worsened. Patient was instructed to wait 30 minutes when receiving 2nd dose administration.
This spontaneous report was received from a medical assistant referring to a 14 month old male patient. The patient don't referred historical condition, concomitant medications and drug reactions or allergies. On 01-FEB-2019, the patient was vaccinated with VARIVAX for varicella, lot # N027619 and expiration date 04-OCT-2019 (dosage schedule, route, anatomical location were not reported). On 13-FEB-2019 (reported as today), the patient woke up with a chicken pox like rash from head to toe (varicella). No treatment was offered. On the same day. The patient's mother called to seek medical attention. Any laboratory diagnostics or studies was performed. On 18-FEB-2019, the patient recovered from varicella. The causality between varicella VARIVAX was unknown.
MOTHER REPORTED CHILD HAD ONSET OF MIGRANE HEADACHES, LEFT ARM NUMBNESS AND SOME BLURRED VISION.  ONSET OCCURRED 1-2 DAYS FOLLOWING THE MENACTRA AND GARDASIL VACCINES.  MOTHER STATES THE HEADACHES HAVE CONTINUED.  PLANS TO CONTACT PEDIATRICIAN FOR EVALUATION.
Presents with altered mental status.  Workup significant for for high ammonia and lactic acid.  Otherwise mostly unremarkable. Incidental COVID-19+, asymptomatic
Swollen lymph nodes in neck opposite side of injection; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01Apr2021 at 10:15 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient received unspecified medication within two weeks of vaccination. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 20:00, the patient experienced swollen lymph nodes in neck opposite side of injection. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lymph nodes was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recv 3 doses of vax as a pre-exposure treatment series & 8AUG97 a rabies titer was performed & reported as 0.4 IU;pt reportedly did not have a viral infect nor took immunosuppressive agents during the series;
severe rigors, myalgias, joint pain, headache, tachypnea to mid-30's.
Sore arm; Low grade fever; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hashimoto's disease, and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 17:00, the patient experienced sore arm, low grade fever, sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore arm, low grade fever, sweats was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
2nd dose of Moderna given today (2/22/2021) 2 weeks early. Patient had no signs or symptoms of adverse reaction following vaccine.
Fever, achy joints and muscles throughout body, difficulty sleeping due to those aches and pain...diarrhea
This spontaneous report as received from a physician via a company representative refer to a 14 year old female patient. The patient's relevant medical history was not reported. On an unknown date, the patient was vaccinated with a first dose of GARDASIL (route, dose, lot# and expiration date were not reported). Information about concomitant medication was not reported. On an unknown date, after receiving the first dose of GARDASIL, the patient developed an unspecified rash in an unspecified location. On an unknown date, the patient was vaccinated with the second dose of GARDASIL (route, dose, lot# and expiration date were not reported) and after the second vaccination, on an unknown date, the patient experienced dizziness, vomiting and "near syncope" stated. The outcome of the events was unknown. The relatedness between the events and GARDASIL was not reported. Additional information has been requested.
Pt noticed that she had chills over night and when she woke up in the morning, her arm was swollen and painful, from the infection site down. Pt declined an appt and decided to use home care to treat.
On Feb 9 and Feb 11 I had an allergic reaction with rash, hives, swollen eyes and tight scratchy throat and needed IV drugs to stop the spread and relieve the symptoms.  I was in the ER 2 times in a 48 hour period.
Pain in right arm and then shoulder. Progressed to back muscles ending with 3 days in hospital.
I had no adverse reaction and I did have another booster in November of 2022 but over the Christmas Holiday I had a very light case of COVID-19 I took Paxlovid and was well in a few days or five days.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 10-JUN-2015, the patient was vaccinated with a dose of improperly stored MMR II (Albumin status of HSA (human serum albumin)), lot number K015374, expiration date 18-SEP-2016. No adverse symptoms reported. This is one of several reports from the same source. Additional information has been requested.
Right arm warm to touch, some swelling, painful to move, pain goes from shoulder joint down to fingers.
On June 14, within 30 seconds of the vaccine, I experienced head issues (dizziness, light headedness + disequilibrium). The head issues were severe for the first 2.5 hours such that I could not leave the facility. The issues subsided some, but persisted for 4-5 days, during which I could not leave the couch. On July 3, 19 days after the vaccination, the severe head issues returned. Over the course of the next five weeks, I experienced severe issues that resulted in pain, fine motor skills issues, twitching, weakness, tingling, numbness and vibrating sensations throughout my body. I also experienced severe visual and auditory sensory issues, slurred speech, tinnitus, joint pain, and nausea. I also had muscular spasm episodes that progressed up the body and impacted a different area every night for several nights in a row. I visited a PCP, ENT, and three hospital ERs during this time. I was finally admitted to the hospital on the third visit because the head issues were so severe that I vomited 21 times that day and needed to be treated for hyponatremia. It took weeks to regain strength. In October, I began to experience on and off tingling, twitching and buzzing sensations again in different areas of the body that lasted several weeks. I spent the entire month of December going through another 4-5 week episode that was similar to what I experienced in July/August of 2021, but slightly less severe. A PCP confirmed that sodium was not an issue, a rheumatologist ruled out all rheumatology diseases, a GI ruled out GI issues, and a neurologist ruled out MS and other related neurological conditions. No healthcare provider seems to know what is going on. I was only taking vitamin D during this most recent month long episode. Despite the many allergy and GI issues I experienced from the giardiasis infection that was treated prior to the vaccine, I never experienced issues like this until taking the vaccine on June 14.
pt recv vax 14SEP95 &  28MAY96 pt devel a yellow, blistery, raised rash described as a typical chickenpox rash;It was considered of moderate severity;
Urticaria for which I have used oral antihistamines and topical steroids. Yet the symptoms still persist.
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 75-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of chills (1st dose received on 18th June 2018, for tolerance see case US2018139571). On 18th August 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced shivering, dizziness, pain in arm, malaise, headache, feeling cold and fever. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the shivering, dizziness, pain in arm, malaise, headache, feeling cold and fever were unknown. It was unknown if the reporter considered the shivering, dizziness, pain in arm, malaise, headache, feeling cold and fever to be related to SHINGRIX. Additional details were provided as follows: The patient experienced shivering, dizziness, pain in arm, malaise, headache, feeling cold and fever (similar but milder reaction as that of 1st dose). The patient did not see physician or anyone else for events after 1st dose.
Large rash at vaccination site about 3" in diameter, very large swollen lump under the rash. Area is very hot to the touch and very sore.
Information has been received from a registered nurse concerning a 12 month old female patient with  pertinent medical history and known drug allergies or reactions who on 10-APR-2008, 01-JUL-2008 and -02-SEP-2008 was vaccinated with the first, second and third PO dose of ROTATEQ (lot # 657980/0106X, 660550/0616X, 660876/0304X) respectively. There was no concomitant medication. On 16-FEB-2009 the patient experienced ear infection and the croup. The patient was treated with Augmentin, Orapred and Albuterol. On 06-MAR-2009 the patient developed rotovirus. The patient experienced fever, diarrhea, yellow stool, no vomiting and abdominal pain. The patient was treated with Tylenol and Motrin for the fever by the mother and recommended to get Donnatal, Mylicon drops and biogaia by the prescriber. The stool culture was performed which showed positive for rotavirus and negative for WBC. On 16-MAR-2009, the patient recovered. Additional information has been requested.
Red, warm to touch, tender, painful to left deltoid IM. Dx with cellulitis.
Bad headache (left temple primarily), very tired (slept for almost 24 hrs+ straight), sore muscles throughout entire body, sweats
This spontaneous report was received from a medical assistant referring to a 29 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. In approximately October 2017, reported as 2 months ago the patient was vaccinated with PROQUAD for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse effects were reported.
Swelling, redness, tenderness, warmth and fever - left deltoid 6cm diameter.
Patient became nauseated and vomited in pharmacy lobby within 10 minutes of vaccine administration.  Patient was weak and pale for several minutes before and after vomiting. Patient felt better after about 5 minutes and was able to leave the pharmacy with his guardians.
Patient received her shot 09/17/2002 at approximately 14:00.  By 11:00 09/18/2002, she ran a steady temperature between 101 and 102 degrees.  She had a hive shown on her face then the other side, back of her arm and then on the back of her right calf.  The temperature ran for 5 days.  She was screaming and crying on and off for 5 days.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 06-MAR-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R021055 with expiration date in 01-APR-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001849: US-009507513-1907USA001848: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
No adverse event noted. Pt. recieved vaccine past 12 hours expiration. MD contacted pt. Pt. chooses to recieve repeat dose, done on 10/23.
Approx 6 hrs after injection in left arm, a rash appeared on left hand. Rash was red, itchy, swollen and "bumpy." It spread across top of hand and onto wrist. Also had some very mild constriction of throat. Took one dose of Benadryl about 7:00 PM. Feeling of constriction cleared up completely within a few hours and itchiness improved somewhat. Took second dose of Benadryl about 11:30 PM and went to bed. Rash was 90% gone by the following morning, with just some redness and mild itchiness remaining. Took a final dose of Benadryl about 8:00 AM and rash was completely gone my mid-day.
pain in my arm; swelling in my my armpit; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 08May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain in my arm"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swelling in my my armpit".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a consumer via call center representative and described the occurrence of neutrophils increased in a 75-year-old male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included osteoarthritis. Concomitant products included CELEBREX. In May 2018, the patient received SHINGRIX (intramuscular). On 14th September 2018, less than 5 months after receiving SHINGRIX, the patient experienced neutrophils increased. On an unknown date, the patient experienced discomfort and injection site pain. On an unknown date, the outcome of the neutrophils increased, discomfort and injection site pain were unknown. It was unknown if the reporter considered the neutrophils increased, discomfort and injection site pain to be related to SHINGRIX. Additional details were provided as follows: In March 2018, the patient had normal white blood cell count. In early May 2018, he received SHINGRIX in right deltoid. On 14th September 2018, bloodwork was done and it showed elevated neutrophils. He did not have any acute illness. Other bloodwork was all normal. The only change he could thought of was he discontinued CELEBREX a month before the date of reporting. The patient also reported intermittent pain in arm where he received the injection.
Initial information received on 26-Oct-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves a 16 years old patient of unknown gender who received a dose of vaccine MENACTRA inadvertently on 26-Oct-2018 and had their second dose of unspecified date of June-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included FLUZONE QUADRIVALENT for Immunization. On 26-Oct-2018, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot 46153AA expiry date: 21-Mar-2020 via intramuscular route in the right arm. 1 other doses were administered on unknown date of June-2018 for suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. It was case of actual medication error due to Extra dose administered. No adverse event was experienced. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
This spontaneous report as received from a 67 year old consumer refers to herself. The patient's concurrent conditions included egg allergy and codeine allergy. The patient's medical history included 2 previous rotator cuff tears. On 11-FEB-2013, the patient was vaccinated with a dose ZOSTAVAX subcutaneous (dose and lot number were not reported). No other co-suspects were reported. Concomitant therapies included NEXIUM, ZOCOR, HYDROCODONE, PAXIL, PROCARDIA and AMBIEN. The consumer reported that after getting the vaccine on 11-FEB-2013, she experienced itchy and burning in her hands, groin and the bottom on her feet and she also stated that she experienced itched from back, torso and chest down. She took 2 BENADRYL and it went away in 1 to 2 hours (also reported that she was not treated for the adverse event). The patient said that she was fine at this time. She believed that she had shingles, which had not been confirmed by a physician. Labs diagnostics studies were not performed. The patient did not sought medical attention. At the time of the report, the patient's outcome for the adverse events was unknown. The relatedness for the adverse event with ZOSTAVAX was unknown. Additional information has been requested.